|
DEPDC1 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.038200E-01 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.233800E-01 |
| Normal-vs-Stage2 |
1.163650E-01 |
| Normal-vs-Stage3 |
4.404000E-01 |
| Normal-vs-Stage4 |
8.345400E-01 |
| Stage1-vs-Stage2 |
1.411820E-02 |
| Stage1-vs-Stage3 |
9.863800E-01 |
| Stage1-vs-Stage4 |
2.584400E-01 |
| Stage2-vs-Stage3 |
7.803900E-02 |
| Stage2-vs-Stage4 |
1.639930E-02 |
| Stage3-vs-Stage4 |
3.621400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.097600E-01 |
| Normal-vs-AfricanAmerican |
4.025000E-01 |
| Normal-vs-Asian |
2.233800E-01 |
| Caucasian-vs-AfricanAmerican |
6.531200E-01 |
| Caucasian-vs-Asian |
9.139800E-02 |
| AfricanAmerican-vs-Asian |
7.327800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.319400E-01 |
| Normal-vs-Female |
3.677200E-01 |
| Male-vs-Female |
4.531400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.947800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.176560E-01 |
| Normal-vs-Age(61-80Yrs) |
5.995800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.322200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.588800E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.799000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.740360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.425970E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.957900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.751570E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.668400E-01 |
| Classical-VS-Follicular |
1.963990E-02 |
| Classical-VS-Other |
1.036030E-01 |
| Classical-VS-Normal |
5.232800E-01 |
| Tall-VS-Follicular |
5.478200E-02 |
| Tall-VS-Other |
1.222380E-01 |
| Tall-VS-Normal |
8.136800E-01 |
| Follicular-VS-Other |
9.285000E-01 |
| Follicular-VS-Normal |
1.358800E-01 |
| Other-VS-Normal |
1.504360E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.909400E-01 |
| Normal-vs-N1 |
2.394200E-01 |
| N0-vs-N1 |
7.200400E-01 |
|
|
